Key Takeaways: Crystal meth usually looks like clear or bluish glass-like shards, but it can also appear as a white powder, pressed pill, or colored
Key Takeaways: Quitting meth is hard because the drug alters dopamine regulation in the brain, not because of a lack of willpower or personal failure.
Key Takeaways: Meth recovery follows a biological timeline — dopamine transporter levels begin measurable recovery after 12 to 17 months of sustained abstinence, according to
Key Takeaways: Meth relapse rates fall between 40–60%, according to NIDA — statistically comparable to relapse rates for chronic illnesses like diabetes, hypertension, and asthma.
Key Takeaways: Suboxone (buprenorphine/naloxone) is FDA-approved only for opioid use disorder — it does not act on the dopamine pathways that methamphetamine affects, so it
Key Takeaways: Naltrexone is not FDA-approved for methamphetamine use disorder; its use is off-label and best supported by research when combined with bupropion. The ADAPT-2
Key Takeaways: No medication is currently FDA-approved for methamphetamine use disorder — any medication used is prescribed off-label based on clinical research and judgment. The
Key Takeaways: A meth comedown lasts 1–3 days and is generally low-risk, while withdrawal can last 1–2 weeks and carries higher psychological risk, particularly around
Key Takeaways: Meth withdrawal moves through three distinct stages: the crash (days 1–3), acute withdrawal (days 4–10), and subacute withdrawal (weeks 2–10). The crash phase
Key Takeaways: Meth withdrawal symptoms fall into two main categories: physical (fatigue, hypersomnia, increased appetite) and psychological (depression, anxiety, cravings, paranoia), with the psychological symptoms
Change your life with one call.
You can do it, we can help.
